logo
Share SHARE
FONT-SIZE Plus   Neg

Ennis To Buy Assets & Business Of PrintXcel And Printegra From Cenveo

Ennis, Inc. (EBF) said Monday that it has agreed to buy certain assets of Cenveo's document business including the manufacturing facilities branded under the names PrintXcel and Printegra.

Sales from both businesses are about $80 million annually. The PrintXcel facilities are located in Visalia, California; Toledo, Ohio; Clarkesville, Tennessee and Fairhope, Alabama. The Printegra facilities are located in Livermore, California; Arlington, Texas; Smyrna, Georgia; Indianapolis, Indiana; Fairport, New York; and Greensboro, North Carolina, with a sales office in Jaffrey, NH.

Trade liabilities were assumed in the deal, which is expected to close during February.

The operations will continue to operate under their respective trade names of PrintXcel and Printegra, Ennis said and added that it will continue to manufacture and market the pressure seal product line under the VersaSeal brand name. Substantially all of PrintXcel's and Printegra's employees will be offered positions with Ennis' new operation.

Ennis expects the acquisition to be accretive to its earnings in the first full year of operations.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
British drug maker AstraZeneca Plc reported Friday higher profit in its first quarter, reflecting lower charges and higher revenues. US and emerging markets performed well. Looking ahead, for fiscal 2016, the company continues to expect both revenue and earnings per share to decline a low to mid single-digit percentage at constant exchange rates. International Consolidated Airlines Group S.A. Friday reported profit for the first quarter, compared to loss in the prior year, mainly reflecting higher passenger revenues and increased capacity. For fiscal 2016, IAG still expects to generate an absolute operating profit increase similar to 2015 as it expects to reduce underlying ex-fuel unit costs by around one percent. French drug maker Sanofi reported Friday a higher profit in its first quarter, while net sales were hurt mainly by weak results in Diabetes unit and Venezuela. Excluding Venezuela. Aggregate Group sales increased 3 percent at constant exchange rates. Looking ahead, the company continues to expect 2016 business earnings per share to be broadly stable at CER.
comments powered by Disqus
Follow RTT